Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4034608

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)c1ccc(N2CCC(CC3CCN(C4CCC4)CC3)CC2)cn1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.48
SLC2A1 P11166 1/20 0.41
KCNH2 Q12809 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
L3MBTL3 Q96JM7 2/20 0.36
CHRM4 P08173 1/20 0.36
SCD O00767 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HIF1A Q16665 2/20 0.36
GLA P06280 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MBTD1 Q05BQ5 1/20 0.36
TP53BP1 Q12888 1/20 0.36
L3MBTL4 Q8NA19 1/20 0.36
F10 P00742 2/20 0.35
ITGB3 P05106 2/20 0.35
ITGA2B P08514 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5222509 0.94 HRH3 (0.44) HRH3SLC2A1KCNH2CHRM4SCD
SCHEMBL4032479 0.93 HRH3 (0.53) HRH3KCNH2L3MBTL1L3MBTL3KDM4E
Trifluoroacetic Acid SCHEMBL5210800 0.88 HRH3 (0.55) HRH3SLC2A1KCNH2
Triaziquone SCHEMBL4034604 0.88 HRH3 (0.40) HRH3SLC2A1CHRM4SCDKDM4E
SCHEMBL4035015 0.83 HRH3 (0.53) HRH3L3MBTL1L3MBTL3KMT2AMBTD1
Hydrochloric Acid SCHEMBL4033620 0.82 HRH3 (0.52) HRH3L3MBTL1L3MBTL3CHRM4MBTD1
SCHEMBL5212817 0.81 HRH3 (0.61) HRH3
SCHEMBL4032017 0.81 HRH3 (0.53) HRH3KCNH2
SCHEMBL4033533 0.80 HRH3 (0.56) HRH3KMT2A
SCHEMBL724509 0.79 L3MBTL3 (0.55) HRH3L3MBTL1L3MBTL3KDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638631-B2 Methylene dipiperidine derivatives GLAXO GROUP LIMITED (GB) 2009-12-29 US disclosed
EP-1789410-B1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LTD (GB) 2009-06-17 EP disclosed
US-20080108624-A1 Methylene Dipiperidine Derivatives GLAXO GROUP LIMITED (GB) 2008-05-08 US disclosed
EP-1789410-A1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2007-05-30 EP disclosed
WO-2006029906-A1 METHYLENE DIPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108624-A1 Methylene Dipiperidine Derivatives DRD2, DRD4, PNMT HRH3 620/4885SLC2A1 4208/4885KCNH2 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.